Analysts Offer Insights on Real Estate Companies: National Health Investors (NHI), RLJ Lodging (RLJ) and Regency Centers (REG)
Analysts have been eager to weigh in on the Real Estate sector with new ratings on National Health Investors (NHI), RLJ Lodging (RLJ) and Regency Centers (REG).
Introducing TipRanks MCP for Agents
- Deliver institutional-grade market data directly into Claude, ChatGPT, Cursor, and other MCP-compatible AI tools.
- Designed for personal research, portfolio monitoring, and AI-assisted investment workflows.
National Health Investors (NHI)
In a report released today, Michael Lewis from Truist Financial maintained a Buy rating on National Health Investors, with a price target of $81.00. The company’s shares closed last Thursday at $71.96.
According to TipRanks.com, Lewis is a 5-star analyst with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for National Health Investors with a $88.00 average price target, a 20.7% upside from current levels. In a report issued on May 30, TipRanks – DeepSeek also upgraded the stock to Buy with a $84.00 price target.
See the top stocks recommended by analysts >>
RLJ Lodging (RLJ)
In a report released today, Gregory Miller from Truist Financial maintained a Hold rating on RLJ Lodging, with a price target of $10.00. The company’s shares closed last Thursday at $10.97.
According to TipRanks.com, Miller is a 5-star analyst with an average return of
RLJ Lodging has an analyst consensus of Hold, with a price target consensus of $9.25, representing a -14.3% downside. In a report issued on May 29, TipRanks – DeepSeek also downgraded the stock to Hold with a $11.00 price target.
Regency Centers (REG)
BTIG analyst Michael Gorman maintained a Buy rating on Regency Centers today and set a price target of $85.00. The company’s shares closed last Thursday at $80.69.
According to TipRanks.com, Gorman is a 4-star analyst with an average return of
Currently, the analyst consensus on Regency Centers is a Moderate Buy with an average price target of $84.40, implying a 4.8% upside from current levels. In a report issued on May 29, Truist Financial also maintained a Buy rating on the stock with a $84.00 price target.
Read More on NHI:
Disclaimer & DisclosureReport an Issue
- National Health Investors Advances Sale of Senior Care Portfolio
- National Health Investors Holds 2026 Annual Meeting, Elects Board
- National Health Investors price target lowered to $91 from $97 at BofA
- National Health Investors Bets On SHOP-Led Growth
- NHI Maintains Buy Rating as Capital Recycling Supports FAD Outlook and Valuation vs. Unchanged $90 Price Target
